Literature DB >> 23318688

Differential effectiveness of tianeptine, clonidine and amitriptyline in blocking traumatic memory expression, anxiety and hypertension in an animal model of PTSD.

Phillip R Zoladz1, Monika Fleshner, David M Diamond.   

Abstract

Individuals exposed to life-threatening trauma are at risk for developing post-traumatic stress disorder (PTSD), a debilitating condition that involves persistent anxiety, intrusive memories and several physiological disturbances. Current pharmacotherapies for PTSD manage only a subset of these symptoms and typically have adverse side effects which limit their overall effectiveness. We evaluated the effectiveness of three different pharmacological agents to ameliorate a broad range of PTSD-like symptoms in our established predator-based animal model of PTSD. Adult male Sprague-Dawley rats were given 1-h cat exposures on two occasions that were separated by 10 days, in conjunction with chronic social instability. Beginning 24 h after the first cat exposure, rats received daily injections of amitriptyline, clonidine, tianeptine or vehicle. Three weeks after the second cat exposure, all rats underwent a battery of behavioral and physiological tests. The vehicle-treated, psychosocially stressed rats demonstrated a robust fear memory for the two cat exposures, as well as increased anxiety expressed on the elevated plus maze, an exaggerated startle response, elevated heart rate and blood pressure, reduced growth rate and increased adrenal gland weight, relative to the vehicle-treated, non-stressed (control) rats. Neither amitriptyline nor clonidine was effective at blocking the entire cluster of stress-induced sequelae, and each agent produced adverse side effects in control subjects. Only the antidepressant tianeptine completely blocked the effects of psychosocial stress on all of the physiological and behavioral measures that were examined. These findings illustrate the differential effectiveness of these three treatments to block components of PTSD-like symptoms in rats, and in particular, reveal the profile of tianeptine as the most effective of all three agents. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318688     DOI: 10.1016/j.pnpbp.2013.01.001

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  21 in total

1.  A predator-based psychosocial stress animal model of PTSD in females: Influence of estrous phase and ovarian hormones.

Authors:  Phillip R Zoladz; Paul A D'Alessio; Sarah L Seeley; Charis D Kasler; Cassandra S Goodman; Kasey E Mucher; Alanis S Allison; Ian F Smith; Jordan L Dodson; Thorne S Stoops; Boyd R Rorabaugh
Journal:  Horm Behav       Date:  2019-08-21       Impact factor: 3.587

2.  Acute tianeptine treatment selectively modulates neuronal activation in the central nucleus of the amygdala and attenuates fear extinction.

Authors:  B P Godsil; B Bontempi; F Mailliet; P Delagrange; M Spedding; T M Jay
Journal:  Mol Psychiatry       Date:  2015-01-06       Impact factor: 15.992

3.  Myocardial hypersensitivity to ischemic injury is not reversed by clonidine or propranolol in a predator-based rat model of posttraumatic stress disorder.

Authors:  Boyd R Rorabaugh; Albert D Bui; Sarah L Seeley; Eric D Eisenmann; Robert M Rose; Brandon L Johnson; Madelaine R Huntley; Megan E Heikkila; Phillip R Zoladz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-09-05       Impact factor: 5.067

4.  Myocardial fibrosis, inflammation, and altered cardiac gene expression profiles in rats exposed to a predator-based model of posttraumatic stress disorder.

Authors:  Boyd R Rorabaugh; Nathaniel W Mabe; Sarah L Seeley; Thorne S Stoops; Kasey E Mucher; Connor P Ney; Cassandra S Goodman; Brooke J Hertenstein; Austen E Rush; Charis D Kasler; Aaron M Sargeant; Phillip R Zoladz
Journal:  Stress       Date:  2019-07-26       Impact factor: 3.493

Review 5.  The predator odor avoidance model of post-traumatic stress disorder in rats.

Authors:  Lucas Albrechet-Souza; Nicholas W Gilpin
Journal:  Behav Pharmacol       Date:  2019-04       Impact factor: 2.293

Review 6.  Animal models for posttraumatic stress disorder: An overview of what is used in research.

Authors:  Bart Borghans; Judith R Homberg
Journal:  World J Psychiatry       Date:  2015-12-22

Review 7.  Current Status of Animal Models of Posttraumatic Stress Disorder: Behavioral and Biological Phenotypes, and Future Challenges in Improving Translation.

Authors:  Jessica Deslauriers; Mate Toth; Andre Der-Avakian; Victoria B Risbrough
Journal:  Biol Psychiatry       Date:  2017-11-20       Impact factor: 13.382

8.  Posttraumatic Stress Disorder Disturbs Coronary Tone and Its Regulatory Mechanisms.

Authors:  H Fred Downey; Svetlana S Lazuko; Olga P Kuzhel; Lyudmila E Belyaeva; Eugenia B Manukhina; H Fred Downey; Olga B Tseilikman; Maria V Komelkova; Vadim E Tseilikman
Journal:  Cell Mol Neurobiol       Date:  2017-07-04       Impact factor: 5.046

Review 9.  Noradrenergic dysfunction in Alzheimer's disease.

Authors:  Mary Gannon; Pulin Che; Yunjia Chen; Kai Jiao; Erik D Roberson; Qin Wang
Journal:  Front Neurosci       Date:  2015-06-17       Impact factor: 4.677

10.  Glucocorticoid Abnormalities in Female Rats Exposed to a Predator-Based Psychosocial Stress Model of PTSD.

Authors:  Phillip R Zoladz; Colin R Del Valle; Ian F Smith; Cassandra S Goodman; Jordan L Dodson; Kara M Elmouhawesse; Charis D Kasler; Boyd R Rorabaugh
Journal:  Front Behav Neurosci       Date:  2021-06-18       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.